0 CHECKOUT

U.S. Market for Interventional Cardiology 2009

  • ID: 998447
  • May 2009
  • Region: United States
  • 312 Pages
  • iData Research
Special Offer Banner
25%
OFF
Offer ends 31st Aug 2015

In 2008, the U.S. market for interventional cardiology was valued at $US 4.6 billion. This value represents drug-eluting stents, PTCA balloons, coronary closure devices, bare-metal stents, embolic protection devices, interventional guidewires, diagnostic catheters, intravascular ultrasound (IVUS) catheters, and interventional catheters. Over the forecast period, the market is predicted to decrease in value due to limited sales of drug-eluting stents.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

ALSO AVAILABLE

RELATED PRODUCTS

Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Corporation
  • Merck & Co., Inc.